forbes.com
🌐 75% Global Worthiness
High-Protein Bar David Capitalizes on Ozempic Trend
Peter Rahal, after selling RxBar for $600 million, launched a new high-protein bar called David, which sold over 1 million units in its first six weeks, driven by increased demand from users of weight-loss drugs like Ozempic.
High-Protein Bar David Capitalizes on Ozempic Trend
Peter Rahal, after selling RxBar for $600 million, launched a new high-protein bar called David, which sold over 1 million units in its first six weeks, driven by increased demand from users of weight-loss drugs like Ozempic.
Progress
44% Bias Score
Good Health and Well-being